Artikel
The prevalence of the metabolic syndrome (MS) in non-diabetic German Caucasians: The Sankt Georgen Study (SGS).
Häufigkeit des Metabolischen Syndroms in einer nichtdiabetischen Bevölkerung Süddeutschlands: Die Sankt Georgen Studie (SGS)
Suche in Medline nach
Autoren
Veröffentlicht: | 8. August 2006 |
---|
Gliederung
Text
Increased body weight has a major impact on health, as many cardiovascular (cv) risk factors drastically increase with overweight and obesity. Patients with the MS carry a high risk for cv and metabolic disease. Therefore, early detection of patients with MS is needed.
Aim: To determine the prevalence of MS and obesity in a non-diabetic population.
Patients and methods: SGS is a project of primary care physicians of the city of SG, the Albert-Schweitzer-Klinik, Königsfeld and several universities. Non-diabetic participants were randomly selected for a metabolic assessment. MS was defined according to the Adult Treatment Panel (ATP) III and the recent International Diabetes Federation (IDF) definition.
Results: 641 adults (aged 18-75 years) participated in the study. Overweight and obesity affected 42% and 19% respectively, central adiposity was present in 36% of population, increasing to 66% when the IDF criteria were used. Dyslipidaemia was identified in at least 1/3 of subjects, however, elevated blood pressure (>130/85mmHg) was found in two-thirds of the population. Prevalence of MS was 26% (ATP MS) and 36% (IDF MS) in this population and increased with body weight.
Conclusion: MS is a common disorder in non-diabetic Germans, increasing markedly in overweight and obese individuals. The IDF definition classifies more subjects as sufferers of the syndrome. Overweight and obesity, in particular, central obesity and elevated blood pressure affected a significant proportion of individuals. Intensive preventive measures are needed.
Table 1 [Tab. 1]